Second Phase III trial of Dasiglucagon for treatment of hypoglycemia in patients with Type 1 Diabetes (T1DM)
Phase of Trial: Phase III
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Dasiglucagon (Primary) ; Glucagon
- Indications Hypoglycaemia
- Focus Therapeutic Use
- 07 Dec 2017 Status changed from planning to recruiting, according to a Zealand Pharma media release.
- 03 Jul 2017 According to a Zealand Pharma media release, the company is planning to initiate this trial in the fourth quarter of 2017.
- 24 May 2017 New trial record